SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pump.fun

PUMP (Pump.fun) is trending due to heightened activity on its platform, with some users speculating on boosts from Solana's fee-sharing model. Community sentiment is sharply polarized by recent news of a lawsuit, whistleblower allegations, and legal issues involving a former developer, prompting extensive debate on its legitimacy and future prospects.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Cybersecurity stock Okta is actively discussed following a sector-wide reaction to Anthropics' new Claude Code Security tool, sparking community debate on whether the perceived threat to identity management is overblown or if it presents a buying opportunity, particularly with the recently authorized $1 billion share buyback program.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is trending following its significant $865 million, 10-year AI data center agreement with Nscale Global, a deal that has ignited bullish calls for major revenue growth and a potential short squeeze. However, some in the community remain frustrated by previous delays in deal announcements and the stock's performance compared to peers in the booming AI infrastructure sector.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl Capital is trending amid concerns surrounding its private credit fund's redemption policy changes and asset sales, sparking broader worries about liquidity across the private credit sector. While some fear potential systemic issues and reputational damage, others highlight management's clarification of accelerated capital returns and the strong underlying performance of its diversified asset base.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is trending amid growing anticipation of a major bullish reversal, driven by its near-max token supply after recent dilution, upcoming V4 developments and strategic partnerships, alongside whispers of increasing institutional accumulation in the DeFi sector.

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Veeva Systems Inc - Ordinary Shares - Class A

Veeva Systems is trending as its recent earnings beat and raised guidance are overshadowed by market concerns over Salesforce winning key CRM deals in the competitive life sciences software sector. Investors are debating if the current downturn is an overreaction offering a buying opportunity for a company leveraging AI and a significant share buyback, or a sign of intensifying competitive pressures.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

BROKE CRYPTO is trending as its developer commits to a major pivot from a memecoin to a business focused on AI services, including a deepfake and document verification truth engine, and is pursuing accelerator funding. Despite recent price drops and team departures, the community is actively discussing this strategic shift as a unique 'rebuild' opportunity, encouraging accumulation during the current undervalued state, further bolstered by recent token burns.

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Savara Inc

Savara is trending following the FDA's acceptance of its resubmitted Biologics License Application (BLA) for Molbreevi in autoimmune Pulmonary Alveolar Proteinosis (aPAP) and the granting of Priority Review. The community is actively discussing the drug's potential as the first approved therapy for aPAP, anticipating a significant market opportunity and renewed speculation around a possible acquisition.

Texas Pacific Land Corp. operates as a landowner in the State of Texas. Its surface and royalty ownership allow revenue generation through the entire value chain of oil and gas development, including through fixed fee payments for use of the firm's land, revenue for sales of materials used in the construction of infrastructure, providing sourced water and treated produced water, revenue from its oil and gas royalty interests, and revenues related to saltwater disposal on land. The firm also generates revenue from pipeline, power line and utility easements, commercial leases, material sales and seismic and temporary permits related to a variety of land uses including midstream infrastructure projects and hydrocarbon processing facilities. It operates through the Land and Resource Management and Water Services and Operations segment. The Land and Resource Management segment focuses on managing oil and gas royalty interest and surface. The Water Services and Operations segment refers to the full-service water offerings to operators in the Permian Basin through Texas Pacific Water Resources LLC, a single member Texas limited liability company owned by the company. The company was founded in 1871 and is headquartered in Dallas, TX.

Texas Pacific Land Corporation

Texas Pacific Land Corporation is trending due to widespread community discussion surrounding its vast West Texas land being a prime location for large-scale AI data centers, with rumors of significant partnerships to leverage its abundant water and energy resources. This, coupled with its core oil and gas royalties and a low share float, has ignited strong bullish sentiment regarding its future growth.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is trending due to a polarized community debate over whether AI advancements will disrupt its business or enhance its Intelligent Agreement Management platform, following recent earnings that, despite beating estimates, were met with cautious guidance and analyst downgrades. Amidst a broader software sector downturn, investors are sharply divided between seeing DocuSign as a falling knife vulnerable to AI and competition, or as an undervalued opportunity for long-term growth and potential M&A.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP...

Mereo BioPharma Group plc - Sponsored ADR $MREO Stock Holdings Raised by Aberdeen Group plc

Aberdeen Group plc lifted its stake in shares of Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) by 82.9% during the 3rd quarter, according to its most recent Form 13F filing...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO INVESTOR ALERT: Pomerantz Law...

NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline

NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo...

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit PR Newswire NEW...

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO) Short Interest Update

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) saw a large increase in short interest during the month of January. As of January 30th, there was short interest totaling...

Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately

Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately Shareholders who lost money in shares of Mereo BioPharma Group PLC...

Mereo BioPharma Group plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights - MREO

Mereo BioPharma Group plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights - MREO Mereo BioPharma Group plc Sued for...

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.

MREO
Mereo Biopharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MREO News

MREOMereo Biopharma